Tag: #lifesciences

Like businesses in any other industry, pharmaceutical companies compete with each other. Despite their individual races to the finish line, the mission is the same: develop and produce lifesaving and life-changing treatments that move medicine, and humanity, forward. The recognition of this mutual goal, and the potential of breaking down siloes to share information, has […]

re:Invent is an opportunity to dive into innovative technologies and explore new ideas, and for healthcare and life sciences (HCLS) organizations, it is the time to think about how to reinvent collaborations, improve data driven decision making, and drive new discoveries, all with the goal of improving patient outcomes. At re:Invent 2022, we continued our […]

Blog is guest authored by Nitin Kaul and Guglielmo Iozzia of Merck & Co., Inc. Improving the productivity of manufacturing operations is vital for pharmaceutical companies, so patients can get the critical medicines they need, faster. While patient safety has always been the highest priority, Merck & Co., Inc. (MSD), the leading global biopharmaceutical company, […]

Celebrating its 11th year, AWS re:Invent 2022 is gearing up to deliver a week of inspiring content, educational workshops and boot camps—all with plenty of peer-to-peer networking opportunities. This year’s conference will take place in Las Vegas, NV from November 28th through December 1st, and will have an engaging virtual component for those who cannot […]

Many Life Sciences organizations struggle with lab digitalization that can scale, automate data tasks, enable AI/ML, and create collaborative environments that support diverse R&D efforts. The AWS Digital Lab Strategy is a set of services, architectures, and partners to help take advantage of cloud scale and agility. Efforts to build digital lab capabilities seem to […]

At this year’s Amazon Web Services (AWS) Industry Innovators Summit, Louis Culot, Innovation Strategy Leader, Precision Diagnosis at Philips, explained how the company is using cloud technology to integrate disciplines and data, to make precision medicine in oncology more accessible. In this interview, Lisa McFerrin, Worldwide Head of Genomics Solutions at AWS, continues the conversation […]

Blog guest contributing authored by Ryan Stastny, Product Manager at MuleSoft Clinical trials are highly complex, lengthy, and expensive. They require effective collaboration among many key stakeholders including subjects, sites, sponsors, contract research organizations (CROs), and government agencies. However, the data needed to drive successful outcomes is often siloed and inaccessible where and when it […]

Blog Guest authored by HonChong Chang, Director of Cloud & Devops at Bristol Myers Squibb With operations spread across five continents, global biopharmaceutical company Bristol Myers Squibb’s (BMS) cloud team had too much on their plate serving its multi-account, multi-region project teams, without enough resources or hours in the day. Manual workflows for incoming requests […]

Blog guest-authored by Mustaqhusain Kazi, Global Head of Roche Informatics Strategy and Digital Innovation, and Neeraj Agarwal, Distinguished Enterprise Architect, Foundational Tech, PHC and Science at Roche. In the 1990s, the “blockbuster model” reigned supreme, with pharmaceutical companies designing therapies for larger populations with a one-size-fits-all approach. Today, with increased digitization and an explosion of patient […]

The success of pharmaceutical and biotechnology organizations rests on their ability to bring new therapies to market, which requires submitting clinical trial data to regulatory agencies. However, it involves massive quantities of data and significant manual labor. To automate and optimize the process, life sciences organizations are leveraging curated solutions powered by the cloud—affording them […]